Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NYSE:ANTM

Anthem (ANTM) Stock Price, News & Analysis

Anthem logo

About Anthem Stock (NYSE:ANTM)

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
1.27 million shs
Average Volume
1.21 million shs
Market Capitalization
$116.34 billion
P/E Ratio
14.83
Dividend Yield
1.06%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ANTM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Anthem and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ANTM Stock News Headlines

Is *BSEM* Oversold??
BioStem Technologies Inc. (OTC: BSEM) is emerging as one of the most exciting MedTech stories of 2025. The company delivered record-breaking revenues in 2024 and Q1 2025, including $72.5 million in net revenue for Q1 — a 73% increase over the prior year — and six consecutive quarters of positive adjusted EBITDA. With cash reserves rising to $30.8 million and a growing patent portfolio of 58 issued and 68 pending patents, BSEM is scaling profitably while advancing its proprietary BioREtain® technology, which has shown clinically superior results for chronic, non-healing wounds. National recognition is adding to the momentum, with CEO Jason Matuszewski named EY Entrepreneur of the Year 2025 Florida Award winner, validating the leadership driving this high-growth MedTech powerhouse.tc pixel
See More Headlines

ANTM Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that Anthem investors own include Chemours (CC), Ovintiv (OVV), Charter Communications (CHTR), Adobe (ADBE), APA (APA), Costco Wholesale (COST) and CrowdStrike (CRWD).

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Managed Health Care
Sub-Industry
N/A
Current Symbol
NYSE:ANTM
CIK
1156039
Fax
N/A
Employees
N/A
Year Founded
1944

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
14.83
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
241,085,000
Free Float
N/A
Market Cap
$116.34 billion
Optionable
Optionable
Beta
N/A

Social Links

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NYSE:ANTM) was last updated on 10/16/2025 by MarketBeat.com Staff
From Our Partners